Chaired by Dr. Ian Chau with Mitsuru Sasako, Kei Muro, and Yung-Jue Bang
Held on Saturday 17th December 2016 at the Suntec Singapore Convention and Exhibition Centre
This symposium, chaired by Ian Chau, discussed the latest surgical and oncologic treatments for gastric cancer in the context of an increasingly complex treatment landscape, including patient and tumour characteristics, clinical guidelines, and novel clinical data, with special focus on the multidisciplinary care team setting.
Scientific summary
Faculty bios
Learning objectives
After attending this symposium, learners will be able to:
- Discuss the latest surgical and adjuvant treatments for GC according to patient and tumour characteristics, clinical guidelines and novel clinical data
- Assess the latest neoadjuvant and pre-surgery options for GC according to patient and tumour characteristics, clinical guidelines and novel clinical data in an Asian setting
- Describe the latest clinical trial data regarding translational research into metastatic GC therapy
- Evaluate best practice in the management of GC and how this best practice could be applied in their local healthcare setting
Educational grant
This program is made possible thanks to independent educational sponsorship from Eli Lilly and Company.
Produced by Springer Healthcare IME.
Contact us
Email: IME@springer.com
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
The Campus, 4 Crinan Street
London, N1 9XW, UK